ImmunoGenesis

ImmunoGenesis is a developer of immuno-oncology therapies aimed at creating unparalleled treatments for cold tumors. The company focuses on developing immunotherapies to catalyze effective immune responses in immunologically cold cancers, such as prostate cancer, colorectal cancer, and pancreatic cancer, for the treatment of cancer patients, enabling healthcare professionals to access therapies targeting key mechanisms of immune resistance.